Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction
Jessica L. Mega +9 more
openalex +1 more source
Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications [PDF]
Toby C. Trujillo, Paul P. Dobesh
openalex +1 more source
Cu-diamine ligand-controlled asymmetric Henry reactions and their application in concise total syntheses of linezolid and rivaroxaban. [PDF]
Zhang Y, Xiao W.
europepmc +1 more source
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non‐valvular atrial fibrillation: Results from ROCKET AF [PDF]
Ihab Girgis +9 more
openalex +1 more source
Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study. [PDF]
Kim DH +6 more
europepmc +1 more source
Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System. [PDF]
Sridharan K, Sivaramakrishnan G.
europepmc +1 more source
Heavy menstrual bleeding on rivaroxaban [PDF]
Jignesh P. Patel +7 more
openaire +4 more sources
Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) [PDF]
Jonathan L. Halperin +14 more
openalex +1 more source
The efficacy and safety of extended thromboprophylaxis after colorectal surgery: a systematic review and meta-analysis. [PDF]
Choi JDW +10 more
europepmc +1 more source

